⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL911361 | 0.78 | — | — | |
| SCHEMBL950910 | 0.78 | — | — | |
| SCHEMBL15831101 | 0.78 | — | — | |
| SCHEMBL2745465 | 0.78 | — | — | |
| SCHEMBL652559 | 0.78 | — | — | |
| SCHEMBL14463594 | 0.78 | — | — | |
| SCHEMBL1533089 | 0.78 | — | — | |
| SCHEMBL23668018 | 0.70 | — | — | |
| SCHEMBL22099857 | 0.70 | — | — | |
| SCHEMBL16970367 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240166641-A1 | HETEROCYCLES AND USES THEREOF | KUMQUAT BIOSCIENCES INC. | 2024-05-23 | — | — | US | disclosed |
| US-10174353-B2 | Methods of producing rhamnolipids | EVONIK DEGUSSA GMBH (DE) | 2019-01-08 | — | — | US | disclosed |
| US-20180243402-A1 | BIRD FLU VACCINE COMBINATION COMPRISING VIRUS-LIKE PARTICLES AND NOVEL ADJUVANTS | ACADEMIA SINICA (TW) | 2018-08-30 | — | — | US | disclosed |
| US-20170096695-A1 | Methods of Producing Rhamnolipids | EVONIK OPERATIONS GMBH (DE) | 2017-04-06 | — | — | US | disclosed |
| US-20150352096-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-12-10 | — | — | US | disclosed |
| US-20150086546-A1 | HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR | MILLENNIUM PHARM INC (US) | 2015-03-26 | — | — | US | disclosed |
| US-20140288105-A1 | ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2014-09-25 | — | — | US | disclosed |
| US-20110151554-A1 | METHOD FOR CULTURING AND SUBCULTURING PRIMATE EMBRYONIC STEM CELL, AS WELL AS METHOD FOR INDUCING DIFFERENTIATION THEREOF | NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE (JP) | 2011-06-23 | — | — | US | disclosed |
| US-7524850-B2 | 1-{1-[4-(6-hydroxy-5-isobutyl-3-phenylpyrazin-2-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; serine/threonine protein kinase; antiproliferative | MERCK & CO., INC. (US) | 2009-04-28 | — | — | US | disclosed |
| US-20070142388-A1 | Inhibitors of Akt activity | MERCK SHARP & DOHME CORP. | 2007-06-21 | — | — | US | disclosed |
| EP-1105153-A4 | MULTIVALENT VACCINE FOR (CLOSTRIDIUM BOTULINUM) NEUROTOXIN | OPHIDIAN PHARM INC (US) | 2005-01-19 | — | — | EP | disclosed |
| US-20020143158-A1 | Novel method for purification of recombinant proteins | TAKARA BIO USA, INC. | 2002-10-03 | — | — | US | disclosed |
| EP-1105153-A1 | MULTIVALENT VACCINE FOR (CLOSTRIDIUM BOTULINUM) NEUROTOXIN | OPHIDIAN PHARMACEUTICALS, INC. (US) | 2001-06-13 | — | — | EP | disclosed |
| EP-0917576-A1 | ANTI-HERPESVIRAL AGENTS AND ASSAYS THEREFOR | MEDICAL RESEARCH COUNCIL (GB) | 1999-05-26 | — | — | EP | disclosed |
| EP-0882130-A2 | HUMAN CANCER ANTIGEN OF TYROSINASE-RELATED PROTEIN 1 AND 2 AND GENES ENCODING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-12-09 | — | — | EP | disclosed |
| WO-1998008540-A1 | MULTIVALENT VACCINE FOR CLOSTRIDIUM BOTULINUM NEUROTOXIN | OPHIDIAN PHARMACEUTICALS, INC. (US) | 1998-03-05 | — | — | WO | disclosed |
| WO-1998004708-A1 | ANTI-HERPESVIRAL AGENTS AND ASSAYS THEREFOR | MEDICAL RESEARCH COUNCIL (GB) | 1998-02-05 | — | — | WO | disclosed |
| WO-1997029195-A2 | HUMAN CANCER ANTIGEN OF TYROSINASE-RELATED PROTEIN 1 AND 2 AND GENES ENCODING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-08-14 | — | — | WO | disclosed |
| EP-0499112-A1 | Antibodies against an IgE receptor | F. HOFFMANN-LA ROCHE AG (CH) | 1992-08-19 | — | — | EP | disclosed |